Skip to main content
OpenTrials
Completed

NCT Number: NCT00586937

Quality of Life in Lung Cancer Survivors

The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. Learning about quality of life will help us to develop new services for lung cancer survivors.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Memorial Sloan Kettering Cancer Center

New York, 10065, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of primary Stage IA or IB NSCLC;
  • Underwent surgical resection for NSCLC at MSKCC;
  • From 1 to 5 years and 11 months post-treatment for NSCLC prior to study recruitment;
  • No evidence of disease (NED) at the time of recruitment;
  • Can be reached by telephone;
  • Able to provide informed consent.

Exclusion criteria

  • Undergoing active antineoplastic treatment;
  • Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.

Treatment and study plan

questionnaires or telephone interview

Behavioral

In the first phase, a random sample of lung cancer survivors will complete a comprehensive telephone interview or questionnaire by self-report focusing on assessment of quality of life and related covariates. We estimate the total time for completion of the survey by telephone interview or self-report to be 45-60 minutes. second phase of the study, a subset of telephone survey participants will take part in a focus group discussion that will explore their perceptions of barriers for delivery of post-treatment medical and psychosocial follow-up care.

Primary outcomes

  1. To describe the health-related quality of life (HQOL) of lung cancer survivors and compare their HQOL with age- and gender-appropriate, population-based normative data.

    Time frame: 2 years

Secondary outcomes

  1. To describe and identify covariates of HQOL in lung cancer survivors.

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Collaborators

  • Fox Chase Cancer Center

Registry information

Important dates

Study start
2005
Primary completion
2020
Study completion
2020
First posted
Jan 7, 2008
Registry last updated
Jan 6, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.